| Management target | Revenue 15.0% FY27 |
|---|
| Revenue growth | Revenue rose 11.3% YoY to ₹165.6 Cr, primarily volume-led. |
|---|---|
| Margins | EBITDA margins improved 70 bps YoY to 17.8%. |
| Demand visibility | Strong demand in domestic API and upcoming specialized oncology/peptide segments. |
| Management confidence | Confident, focusing on transitioning to high-value science-led API modules. |
Growth
Revenue grew 11.3% YoY to ₹165.6 Cr, driven by a 27% surge in domestic API volumes.
Outlook
Management guides for 10-15% topline and profit growth in FY27, aiming for ₹1000 Cr revenue by FY29.
Risks
Prolonged high working capital cycles and inventory bunching due to geopolitical risk remain key concerns.
Earnings Call Transcript filed with NSE, NSE: BAJAJHCARE. Summary written with AI assistance from the document.
Bajaj Healthcare Ltd: key numbers
- Share price
- ₹344.15
- Market cap
- ₹1,159 Cr
- Revenue (annual)
- ₹611.0 Cr
- Net profit (annual)
- ₹15.77 Cr
- P/E (TTM)
- 65.7×Sector 50.4×
- Promoter holding
- 58.59%+0.30% QoQ
- FII holding
- 2.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bajaj Healthcare Ltd
All →Bajaj Healthcare Annual General Meeting
Bajaj Healthcare Limited concluded its 33rd Annual General Meeting on September 21, 2026. The shareholders transacted ordinary and special business, including a final dividend declaration.
Bajaj Healthcare Dividend
Bajaj Healthcare Limited has fixed September 14, 2026, as the record date for a 30% final dividend. The dividend of ₹1.50 per share awaits shareholder approval.
Bajaj Healthcare Investor Presentation: Key Takeaways
Q1FY27 revenue grew 11.3% YoY to INR 165.6 Cr with PAT at INR 13.9 Cr. Focus shifting toward high-margin peptides, oncology APIs, and specialized formulations.
- Call
- Guides 12% growth
Bajaj Healthcare Q1 FY27 Results: Net Profit ₹13.7 Cr, Up 16.1% YoY
Bajaj Healthcare Ltd reported revenue from operations of ₹165.6 Cr (+11.3% YoY) and net profit of ₹13.7 Cr (+16.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹13.7 Cr · +16.1% YoY
Bajaj Healthcare Q4 FY26 Results: Net Loss of ₹22.9 Cr
Bajaj Healthcare Ltd reported revenue from operations of ₹153.1 Cr (-0.9% YoY) and a net loss of ₹22.9 Cr for Q4 FY26.
- Key figure
- Net loss ₹22.9 Cr